Brivaracetam (alfaR, 4S)-Isomer
≥98%
- Product Code: 140850
CAS:
357336-99-3
| Molecular Weight: | 212.29 g./mol | Molecular Formula: | C₁₁H₂₀N₂O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | 73-76 °C | Boiling Point: | 409.3±28.0 °C(Predicted) |
| Density: | 1.062±0.06 g/cm3(Predicted) | Storage Condition: | 2-8°C |
Product Description:
Used as an anticonvulsant medication for the treatment of partial-onset seizures in patients with epilepsy. It functions as a synaptic vesicle protein 2A (SV2A) ligand, modulating neurotransmitter release and reducing neuronal hyperexcitability. Due to its high affinity for SV2A and favorable pharmacokinetic profile, it is often prescribed as an adjunctive therapy in adults and children. Its isomeric purity contributes to enhanced efficacy and reduced side effects compared to related compounds.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 10mg | 10-20 days | $1,271.55 |
+
-
|
Brivaracetam (alfaR, 4S)-Isomer
Used as an anticonvulsant medication for the treatment of partial-onset seizures in patients with epilepsy. It functions as a synaptic vesicle protein 2A (SV2A) ligand, modulating neurotransmitter release and reducing neuronal hyperexcitability. Due to its high affinity for SV2A and favorable pharmacokinetic profile, it is often prescribed as an adjunctive therapy in adults and children. Its isomeric purity contributes to enhanced efficacy and reduced side effects compared to related compounds.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
$0.00
$0.00
Total :